Peggi M Angel1, Laura Spruill2, Melanie Jefferson3, Jennifer R Bethard1, Lauren E Ball1, Chanita Hughes-Halbert3, Richard R Drake1. 1. Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Proteomics Center, Medical University of South Carolina, Charleston, South Carolina. 2. Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina. 3. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina.
Abstract
BACKGROUND: The emergence of reactive stroma is a hallmark of prostate cancer (PCa) progression and a potential source for prognostic and diagnostic markers of PCa. Collagen is a main component of reactive stroma and changes systematically and quantitatively to reflect the course of PCa, yet has remained undefined due to a lack of tools that can define collagen protein structure. Here we use a novel collagen-targeting proteomics approach to investigate zonal regulation of collagen-type proteins in PCa prostatectomies. METHODS: Prostatectomies from nine patients were divided into zones containing 0%, 5%, 20%, 70% to 80% glandular tissue and 0%, 5%, 25%, 70% by mass of PCa tumor following the McNeal model. Tissue sections from zones were graded by a pathologist for Gleason score, percent tumor present, percent prostatic intraepithelial neoplasia and/or inflammation (INF). High-resolution accurate mass collagen targeting proteomics was done on a select subset of tissue sections from patient-matched tumor or nontumor zones. Imaging mass spectrometry was used to investigate collagen-type regulation corresponding to pathologist-defined regions. RESULTS: Complex collagen proteomes were detected from all zones. COL17A and COL27A increased in zones of INF compared with zones with tumor present. COL3A1, COL4A5, and COL8A2 consistently increased in zones with tumor content, independent of tumor size. Collagen hydroxylation of proline (HYP) was altered in tumor zones compared with zones with INF and no tumor. COL3A1 and COL5A1 showed significant changes in HYP peptide ratios within tumor compared with zones of INF (2.59 ± 0.29, P value: .015; 3.75 ± 0.96 P value .036, respectively). By imaging mass spectrometry COL3A1 showed defined localization and regulation to tumor pathology. COL1A1 and COL1A2 showed gradient regulation corresponding to PCa pathology across zones. Pathologist-defined tumor regions showed significant increases in COL1A1 HYP modifications compared with COL1A2 HYP modifications. Certain COL1A1 and COL1A2 peptides could discriminate between pathologist-defined tumor and inflammatory regions. CONCLUSIONS: Site-specific posttranslational regulation of collagen structure by proline hydroxylation may be involved in reactive stroma associated with PCa progression. Translational and posttranslational regulation of collagen protein structure has potential for new markers to understand PCa progression and outcomes.
BACKGROUND: The emergence of reactive stroma is a hallmark of prostate cancer (PCa) progression and a potential source for prognostic and diagnostic markers of PCa. Collagen is a main component of reactive stroma and changes systematically and quantitatively to reflect the course of PCa, yet has remained undefined due to a lack of tools that can define collagen protein structure. Here we use a novel collagen-targeting proteomics approach to investigate zonal regulation of collagen-type proteins in PCa prostatectomies. METHODS: Prostatectomies from nine patients were divided into zones containing 0%, 5%, 20%, 70% to 80% glandular tissue and 0%, 5%, 25%, 70% by mass of PCa tumor following the McNeal model. Tissue sections from zones were graded by a pathologist for Gleason score, percent tumor present, percent prostatic intraepithelial neoplasia and/or inflammation (INF). High-resolution accurate mass collagen targeting proteomics was done on a select subset of tissue sections from patient-matched tumor or nontumor zones. Imaging mass spectrometry was used to investigate collagen-type regulation corresponding to pathologist-defined regions. RESULTS: Complex collagen proteomes were detected from all zones. COL17A and COL27A increased in zones of INF compared with zones with tumor present. COL3A1, COL4A5, and COL8A2 consistently increased in zones with tumor content, independent of tumor size. Collagen hydroxylation of proline (HYP) was altered in tumor zones compared with zones with INF and no tumor. COL3A1 and COL5A1 showed significant changes in HYP peptide ratios within tumor compared with zones of INF (2.59 ± 0.29, P value: .015; 3.75 ± 0.96 P value .036, respectively). By imaging mass spectrometry COL3A1 showed defined localization and regulation to tumor pathology. COL1A1 and COL1A2 showed gradient regulation corresponding to PCa pathology across zones. Pathologist-defined tumor regions showed significant increases in COL1A1 HYP modifications compared with COL1A2 HYP modifications. Certain COL1A1 and COL1A2peptides could discriminate between pathologist-defined tumor and inflammatory regions. CONCLUSIONS: Site-specific posttranslational regulation of collagen structure by proline hydroxylation may be involved in reactive stroma associated with PCa progression. Translational and posttranslational regulation of collagen protein structure has potential for new markers to understand PCa progression and outcomes.
Authors: Rebecca Hjorten; Uwe Hansen; Robert A Underwood; Helena E Telfer; Russell J Fernandes; Deborah Krakow; Eiman Sebald; Sebastian Wachsmann-Hogiu; Peter Bruckner; Robin Jacquet; William J Landis; Peter H Byers; James M Pace Journal: Bone Date: 2007-07-13 Impact factor: 4.398
Authors: Peggi M Angel; Evelyn Bruner; Jennifer Bethard; Cassandra L Clift; Lauren Ball; Richard R Drake; Carol Feghali-Bostwick Journal: J Mass Spectrom Date: 2020-02-21 Impact factor: 1.982
Authors: William E Grizzle; Rick A Kittles; Soroush Rais-Bahrami; Ebony Shah; George W Adams; Mark S DeGuenther; Peter N Kolettis; Jeffrey W Nix; James E Bryant; Ravi Chinsky; James E Kearns; Kerry Dehimer; Norma Terrin; Hong Chang; Sandra M Gaston Journal: Cancer Med Date: 2019-09-30 Impact factor: 4.452
Authors: Natalia Davidenko; Samir Hamaia; Daniel V Bax; Jean-Daniel Malcor; Carlos F Schuster; Donald Gullberg; Richard W Farndale; Serena M Best; Ruth E Cameron Journal: Acta Biomater Date: 2017-10-26 Impact factor: 8.947
Authors: Cassandra L Clift; Sarah McLaughlin; Marcelo Muñoz; Erik J Suuronen; Benjamin H Rotstein; Anand S Mehta; Richard R Drake; Emilio I Alarcon; Peggi M Angel Journal: J Am Soc Mass Spectrom Date: 2021-10-29 Impact factor: 3.109
Authors: Cassandra L Clift; Yan Ru Su; David Bichell; Heather C Jensen Smith; Jennifer R Bethard; Kim Norris-Caneda; Susana Comte-Walters; Lauren E Ball; M A Hollingsworth; Anand S Mehta; Richard R Drake; Peggi M Angel Journal: Sci Rep Date: 2021-05-07 Impact factor: 4.379
Authors: Therese S Høiem; Maria K Andersen; Marta Martin-Lorenzo; Rémi Longuespée; Britt S R Claes; Anna Nordborg; Frédéric Dewez; Benjamin Balluff; Marco Giampà; Animesh Sharma; Lars Hagen; Ron M A Heeren; Tone F Bathen; Guro F Giskeødegård; Sebastian Krossa; May-Britt Tessem Journal: Proteomics Date: 2022-03-03 Impact factor: 5.393
Authors: Denys Rujchanarong; Julia Lefler; Janet E Saunders; Sarah Pippin; Laura Spruill; Jennifer R Bethard; Lauren E Ball; Anand S Mehta; Richard R Drake; Michael C Ostrowski; Peggi M Angel Journal: Cancers (Basel) Date: 2021-09-01 Impact factor: 6.639